PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Pacific Biosciences Of California, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Pacific Biosciences Of California, Inc. Return On Equity for the quarter ending June 30, 2024 was -61.4 %, a 21.4% decline year-over-year.
  • Pacific Biosciences Of California, Inc. annual Return On Equity for 2023 was -43.8 %, a 9.12% increase from 2022.
  • Pacific Biosciences Of California, Inc. annual Return On Equity for 2022 was -48.2 %, a 44.4% decline from 2021.
  • Pacific Biosciences Of California, Inc. annual Return On Equity for 2021 was -33.4 %, a 261% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -61.4 -10.8 -21.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 -43.1 +6.96 +13.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -43.8 +4.4 +9.12% Oct 1, 2023 Dec 31, 2023
Q3 2023 -46.5 -4.24 -10% Jul 1, 2023 Sep 30, 2023
Q2 2023 -50.6 -23.6 -87.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -50.1 -23.3 -87.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -48.2 -14.8 -44.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -42.2 -33.6 -390% Jul 1, 2022 Sep 30, 2022
Q2 2022 -27 +3.78 +12.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -26.7 +3.43 +11.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -33.4 -54.2 -261% Oct 1, 2021 Dec 31, 2021
Q3 2021 -8.62 +55.1 +86.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -30.8 +67.5 +68.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -30.1 +56.7 +65.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 20.8 +142 Oct 1, 2020 Dec 31, 2020
Q3 2020 -63.8 +73.1 +53.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 -98.3 +8.08 +7.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 -86.8 +15.2 +14.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -122 -27.2 -28.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 -137 -45.7 -50.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -106 -11.1 -11.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -102 -10.9 -12% Jan 1, 2019 Mar 31, 2019
Q4 2018 -94.5 +4.49 +4.54% Oct 1, 2018 Dec 31, 2018
Q3 2018 -91.1 +6.38 +6.54% Jul 1, 2018 Sep 30, 2018
Q2 2018 -95.3 -1.98 -2.12% Apr 1, 2018 Jun 30, 2018
Q1 2018 -91.1 -3.6 -4.11% Jan 1, 2018 Mar 31, 2018
Q4 2017 -99 -20.7 -26.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -97.5 -36 -58.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 -93.3 -45.3 -94.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 -87.5 -35.5 -68.3% Jan 1, 2017 Mar 31, 2017
Q4 2016 -78.3 -11.3 -16.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 -61.5 +54 +46.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -48 +84.2 +63.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -52 +78 +60% Jan 1, 2016 Mar 31, 2016
Q4 2015 -67 +42.1 +38.6% Oct 1, 2015 Dec 31, 2015
Q3 2015 -115 -15.1 -15.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -132 -26.7 -25.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 -130 -36.2 -38.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 -109 -21.1 -23.9% Oct 1, 2014 Dec 31, 2014
Q3 2014 -100 -16.7 -20% Jul 1, 2014 Sep 30, 2014
Q2 2014 -105 -28.3 -36.6% Apr 1, 2014 Jun 30, 2014
Q1 2014 -93.8 -22.5 -31.5% Jan 1, 2014 Mar 31, 2014
Q4 2013 -88.1 -19.9 -29.1% Oct 1, 2013 Dec 31, 2013
Q3 2013 -83.6 -23.5 -39.1% Jul 1, 2013 Sep 30, 2013
Q2 2013 -77.2 -20.3 -35.7% Apr 1, 2013 Jun 30, 2013
Q1 2013 -71.4 -20.5 -40.3% Jan 1, 2013 Mar 31, 2013
Q4 2012 -68.2 Oct 1, 2012 Dec 31, 2012
Q3 2012 -60.1 Jul 1, 2012 Sep 30, 2012
Q2 2012 -56.9 Apr 1, 2012 Jun 30, 2012
Q1 2012 -50.9 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.